UCSF

Tagged: mass spectrometry

QBI pioneers a collaborative and inclusive approach to scientific discovery

UCSF’s Quantitative Biosciences Institute (QBI), founded two years ago, is making waves with its unique approach to scientific collaboration, catalyzing discoveries from cancer to psychiatry while supporting female scientists and engaging with the public.

A pop-up repair shop for damaged neurons

Collaborative research holds promise for harnessing the nervous system’s own repair programs.

Taking a bite out of the proteome with PhaNGS

If DNA is the blueprint for every cell in the body, then proteins are the cell’s construction workers, forklifts, and building materials.

Unmasking a cellular hallmark of cancer

Scientists identify a signature of cancers caused by mutant RAS that may lead to precise therapies.

Research: Elusive drug targets; cell demolition enzymes; useful pharmacogenomics info

Predicting difficult-to-detect drug binding sites

Craik receives Protein Society’s Emil Thomas Kaiser Award

Charles S. Craik, PhD, faculty member in the School’s Department of Pharmaceutical Chemistry, has been named the 2016 recipient of the Protein Society’s Emil Thomas Kaiser Award.

Burlingame and Gross labs shed light on braking mechanisms in cellular signaling

How do cells that must respond rapidly and robustly to changes in the environment subsequently modulate that response so such elevated activity doesn’t prove harmful? Put another way: How do cells put the brakes on their response to external signaling in order to re-stabilize themselves?

Al Burlingame, PhD

Professor

My research interests focus on the development of state of the art methodologies in mass spectrometry for use in advancing our global knowledge of human biology, specifically the dynamic, epigenetic modulation and regulation of the proteome.

Artificial kidney project led by Roy cited at White House panel

Speaking on a White House panel discussing President Obama's just-released Bioeconomy Blueprint, UCSF Vice Chancellor for Research Keith Yamamoto, PhD, cited the implantable bioartificial kidney project led by UCSF b

Celebrating Burlingame’s contributions to mass spectrometry

From the start of his illustrious half-century career in mass spectrometry, Al Burlingame, PhD, has been part of a scientific sea change.

Pages